SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-07-000132
Filing Date
2007-02-12
Accepted
2007-02-12 15:54:43
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 pharmadrugdis.htm SC 13G/A 105498
  Complete submission text file 0000898432-07-000132.txt   107706
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address P.O. BOX 5350 PRINCETON NJ 08543-5350
Business Address P.O. BOX 5350 PRINCETON NJ 08543-5350 609-452-3600
PHARMACOPEIA DRUG DISCOVERY INC (Subject) CIK: 0001273013 (see all company filings)

IRS No.: 510418085 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-79837 | Film No.: 07602953
SIC: 8731 Services-Commercial Physical & Biological Research